CLE

M&A in Pharmaceutical: Deal Structures - Part 4

schedule 2h 54m signal_cellular_alt Advanced category Corporate Tax verified 24 credits available

About This Course

This on-demand CLE program offers sophisticated and nuanced coverage of m&a in pharmaceutical: deal structures - part 4.

Participants will gain a deep understanding of the fundamental concepts, current best practices, and emerging trends in this area. The program addresses real-world challenges practitioners face and provides concrete strategies for handling common situations effectively.

Specifically designed for corporate tax professionals, this course covers both foundational principles and advanced applications. Through clear explanations and practical examples, you will develop the skills needed to confidently navigate complex issues and deliver superior results for your clients or organization.

Key topics include regulatory requirements, compliance considerations, strategic decision-making, and risk management. Whether you are new to this area or looking to update your knowledge, this program provides the insights and tools necessary for success in today's evolving professional landscape.

Presented By

RX

Rafael X. Zahralddin-Aravena open_in_new

Partner • Lewis Brisbois

Mr. Zahralddin-Aravena is a member of the Corporate, Bankruptcy, Complex Business disputes practice.

Credits & Accreditations

Jurisdiction Credit Type Credits
Alaska General 1.0
Arizona General 2.0
Arkansas Diversity 1.5
California Ethics 3.0
Connecticut General 1.0
Florida General 1.0
Georgia Diversity 1.5
Hawaii General 2.0
Idaho General 3.5
Indiana General 1.5
Iowa General 3.5
Kansas Ethics 1.0
Maryland General 1.0
Massachusetts General 3.5
Michigan General 2.5
Mississippi General 1.0
Nebraska General 3.5
New York General 3.5
Pennsylvania Ethics 2.0
Puerto Rico General 3.0
South Carolina Ethics 3.0
Tennessee General 3.5
Vermont Ethics 1.5
Washington General 1.0
$235.00